FindTrial
Sign In

Addition of opening positions to nerve mobilization on pain, range of motion and leg functions in participants having piriformis syndrome.

Additive effect of static openers to sciatic nerve mobilization on pain, range of motion and lower extremity functions in individuals with piriformis syndrome. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085369
Enrollment
30
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R298- Other symptoms and signs involvingthe nervous and musculoskeletal systems

Interventions

Intervention1: Neurodynamic mobilization And Static openers for sciatic nerve.: Static openers Position painful side uppermost with a bolster under the lower side & towel between ilium and trochante

Sponsors

Apoorva Saini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals suffering from piriformis syndrome. Patients expressing a readiness to take part in the study. Both males and females. 19-45 years of age. Individuals having positive special test Beatty maneuver , Fair test ,SLR sensitivity test.1

Exclusion criteria

Exclusion criteria: Individuals suffering from any other neurological conditions. Individuals having any history of trauma or surgery in previous six months. Spondylolisthesis. Degeneration of both spine and hip joint . Unwilling to actively participate

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS). Pain Pressure Threshold (PPT) Of piriformis muscle. Lower Extremity Functional Scale (LEFS) Hip rotation ROM Timepoint: Outcome measured at baseline 1st day and at 5th/last day of intervention.—

Secondary

MeasureTime frame
Visual Analogue Scale (VAS). Pain Pressure Threshold (PPT) Of piriformis muscle. Lower Extremity Functional Scale (LEFS) Hip rotation ROM Timepoint: Outcome measured at baseline 1st day & at 5th/last day of intervention.—

Countries

India

Contacts

Public ContactApoorva saini

MMIPR Mullana

apoorvasaini273@gmail.com8077131964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026